IL-2 Clinical Trials
5 recruitingDrug
Phase 14Phase 22
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
AML, Childhood
Washington University School of Medicine68 enrolled1 locationNCT06158828
Recruiting
Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Chronic Lymphocytic LeukemiaNon-Hodgkin LymphomaSmall Lymphocytic Lymphoma+1 more
Imugene Limited135 enrolled23 locationsNCT03666000
Recruiting
Phase 1
NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors
Advanced Solid Tumors
TCRCure Biopharma Ltd.18 enrolled1 locationNCT05881525
Recruiting
Phase 1
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
Advanced Solid TumorImmunotherapyTumor Associated Lymph Node T Cell
Guangzhou FineImmune Biotechnology Co., LTD.23 enrolled1 locationNCT06302062
Recruiting
Phase 2
Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients
Malignant Melanoma Stage IV
Sheba Medical Center30 enrolled1 locationNCT03166397